Finally, we determined α-Synuclein33 and MAO-B mRNA and protein levels, two other reported downstream targets of C/EBPβ, in AD and other neurodegenerative disease such as PD and PSP. This evidence concerns the gene MAOB and supranuclear palsy, progressive, 1.